Cancer Treatment and Research Communications : Impact Factor & More
eISSN: 2468-2942
Open AccessShare this on:
Key Metrics
CiteScore 
1
SJR
Q4Oncology
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Cancer Treatment and Research Communications
Cancer Treatment and Research Communications Journal Specifications
Indexed in the following public directories
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | Elsevier |
| Language | English |
| Article Processing Charges | USD 1650 |
| Publication Time | 17 |
| Editorial Review Process | Blind peer review |
| General Details | |
| Language | English |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| License type | CC BY, CC BY-NC-ND |
| OA statement | Visit website |
View less
Planning to publish in Cancer Treatment and Research Communications ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Cancer Treatment and Research Communications
Uncovering the transcriptomic basis of endoxifen resistance in ER+ breast cancer cells: Insights from bioinformatics analysis.
- 22 Nov 2025
- Cancer treatment and research communications
Epidemiology and treatments of neuroendocrine prostate cancer in a large commercially insured population in the US.
- 17 Nov 2025
- Cancer treatment and research communications
Investigating the quality of sexual function in women with genital cancers: A structural equation analysis approach.
- 12 Nov 2025
- Cancer treatment and research communications
Validation of the pheochromocytoma of adrenal gland scaled score (PASS) grading system: A retrospective double-centered cross-sectional study.
- 7 Nov 2025
- Cancer treatment and research communications
3-month postoperative efficacy evaluation of CT-guided 125I seed implantation treatment for intracranial tumors: A double-center retrospective analysis.
- 1 Nov 2025
- Cancer treatment and research communications
Neoadjuvant FOLFOXIRI for locally advanced rectal cancer: A retrospective analysis focusing on long-term anal preservation
- 1 Nov 2025
- Cancer Treatment and Research Communications
Uncovering the transcriptomic basis of endoxifen resistance in ER+ breast cancer cells: Insights from bioinformatics analysis.
- 22 Nov 2025
- Cancer treatment and research communications
Epidemiology and treatments of neuroendocrine prostate cancer in a large commercially insured population in the US.
- 17 Nov 2025
- Cancer treatment and research communications
Investigating the quality of sexual function in women with genital cancers: A structural equation analysis approach.
- 12 Nov 2025
- Cancer treatment and research communications
Validation of the pheochromocytoma of adrenal gland scaled score (PASS) grading system: A retrospective double-centered cross-sectional study.
- 7 Nov 2025
- Cancer treatment and research communications
3-month postoperative efficacy evaluation of CT-guided 125I seed implantation treatment for intracranial tumors: A double-center retrospective analysis.
- 1 Nov 2025
- Cancer treatment and research communications
Neoadjuvant FOLFOXIRI for locally advanced rectal cancer: A retrospective analysis focusing on long-term anal preservation
- 1 Nov 2025
- Cancer Treatment and Research Communications
FAQs on Cancer Treatment and Research Communications
How many articles did Cancer Treatment and Research Communications publish last year? 
What is Citescore for Cancer Treatment and Research Communications?
What is the SJR for Cancer Treatment and Research Communications?
Who is the publisher of Cancer Treatment and Research Communications?
